Skip to main content

Peer Review reports

From: Attitudes and practices in the laboratory monitoring of conventional synthetic disease modifying anti-rheumatic drugs by rheumatologists and rheumatology trainees

Original Submission
13 Mar 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
9 Apr 2022 Reviewed Reviewer Report
24 May 2022 Reviewed Reviewer Report
14 Jun 2022 Author responded Author comments - Philip C. Robinson
Resubmission - Version 4
14 Jun 2022 Submitted Manuscript version 4
19 Jun 2022 Author responded Author comments - Philip C. Robinson
Resubmission - Version 5
19 Jun 2022 Submitted Manuscript version 5
20 Jun 2022 Author responded Author comments - Philip C. Robinson
Resubmission - Version 6
20 Jun 2022 Submitted Manuscript version 6
30 Jun 2022 Author responded Author comments - Philip C. Robinson
Resubmission - Version 7
30 Jun 2022 Submitted Manuscript version 7
1 Jul 2022 Author responded Author comments - Philip C. Robinson
Resubmission - Version 8
1 Jul 2022 Submitted Manuscript version 8
Publishing
11 Jul 2022 Editorially accepted
17 Oct 2022 Article published 10.1186/s41927-022-00290-y

You can find further information about peer review here.

Back to article page